[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Australia update with Dr Farrier", "description": "Update on prevention of community transmission in Australia, followed by vaccinations update. Discussions on the Indian situation and the prospects for viral elimination.\nhttps://www.wa.gov.au/government/covid-19-coronavirus\nAlso a recent survey on people wanting the vaccine in Australia\"\nhttps://www.msn.com/en-au/money/markets/only-40percent-of-australians-want-the-astrazeneca-vaccine-what-could-this-mean-for-csl-asxcsl/ar-BB1gcgqj?ocid=sf", "link": "https://www.youtube.com/watch?v=UgylurAiye4", "date_published": "2021-04-30 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "UK vaccines data", "description": "Here\u2019s what we know so far about the after effects of the Pfizer COVID vaccine\n\nhttps://covid.joinzoe.com/post/covid-vaccine-pfizer-effects\n\nHere\u2019s what we know so far about the after effects of the Oxford AstraZeneca COVID vaccine\n\nhttps://covid.joinzoe.com/post/covid-vaccine-astrazeneca-effects\n\nHow to tell the difference between COVID-19 symptoms and vaccine after effects\n\nhttps://covid.joinzoe.com/post/covid-symptoms-or-vaccine-after-effects\n\nVaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study\n\nhttps://covid.joinzoe.com/post/covid-vaccine-data-lancet\n\nhttps://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00224-3/fulltext\n\nPfizer-BioNTech (BNT162b2)\n\nOxford-AstraZeneca (ChAdOx1 nCoV-19)\n\nSafety and effectiveness in UK community setting\n\n1,607,620 users (2\u00b74% of the UK population)\n\nMethods\n\nProspective observational study\n\nSelf-reported systemic and local side-effects within 8 days\n\nAfter one or two doses\n\nInfection rates, after vaccine, diagnosed by PCR or lateral flow\n\nUnvaccinated controls\n\nFindings\n\nDec 8th 2020, and March 10th 2021\n\nVaccinated reporters, n = 627\u2009383\n\nReactogenicity, (common, expected)\n\nSystemic side-effects\n\nFatigue and headache (about 4% each)\n\nMost frequently within the first 24 h\n\nLasted a mean of 1\u00b701 days \n\nFever\n\nChills or shivers\n\nNausea\n\nDiarrhoea\n\nMuscle pains\n\nJoint pains\n\nLocal side effects\n\nTenderness and local pain\n\nRedness\n\nSwollen armpit glands\n\nWarmth\n\nItch\n\nBruising\n\nPfizer\n\nOne dose, 282,\u2009103 (13% SSE) (71.9% LSE)\n\nTwo doses, 28,\u2009207 (22% SSE) (68.5% LSE)\n\nMedian, 41 days apart\n\nOxford AZ\n\nOne dose, 345\u2009280 (33.7% SSE) (58.7% LSE)\n\nIn those with past infection after Pfizer\n\nSSE x 2.9\n\nLSE x 1.2\n\nIn those with past infection after Oxford AZ\n\nSSE x 1.6\n\nLSE x 1.4\n\nVaccinated people who became infected\n\nVaccine group, 3,106 of 103,622\n\nUnvaccinated controls, 50,340 of 464,356\n\nReductions in infection risk\n\nStarted at 12 days after the first dose, to 21 days\n\nReaching - 60% Oxford AZ\n\nReaching - 58% for the Pfizer\n\nLonger term benefits of vaccination after Pfizer\n\nRR, 21 to 44 days - 69%\n\nRR, 45 to 59 days, - 72%\n\nIn conclusion, short-term adverse effects of both vaccines are moderate in frequency, mild in severity, and short-lived. \n\nAdverse effects are more frequently reported in younger individuals, women, and among those who previously had COVID-19. \n\nThe post-vaccine symptoms (both systemic and local) often last 1\u20132 days from the injection. \n\nOur data could be used to inform people on the likelihood of side-effects on the basis of their age and sex and the type of vaccine being administered. \n\nFurthermore, our data support results from randomised controlled trials in a large community-based scenario showing evidence of reduction in infection after 12 days and substantial protection after 3 weeks.", "link": "https://www.youtube.com/watch?v=9t4y1-gSj_U", "date_published": "2021-04-30 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "UK moves to endemic", "description": "UK\nCases, + 2,445 (+15,811 past 7 days) = 4,414,242\n\nDown 8.6% on the week\n\nLowest weekly figure since 2nd September\n\nCovid symptom study\n\nhttps://covid.joinzoe.com/data#levels-over-time\n\nhttps://www.youtube.com/watch?v=Q1UJxFyXqR0\n\nLowers rate of symptomatic infection since May 2020\n\nMoving from pandemic to endemic\n\nLower levels with occasional outbreaks\n\nDeaths down\n\nStrain on NHS down\n\nDespite relaxations\n\nRoad map should continue\n\nChances of getting infection in next 24 hours\n\nNot vaccinated, 1 in 45,000\n\nOne vaccine, 12 days later, 1 in 100,000\n\nTwo vaccines, 1 in 150,000\n\nAfter a million reports\n\n31 people had a positive test after 2nd vaccine\n\n87 after first dose\n\nSymptoms are milder\n\nStill at risk of mild disease\n\nTest if in doubt\n\nDeaths, + 22 (+157 past 7 days) = 127,502\n\nUp 0.6% on the week\n\nDeaths, = 151,243 certificated\n\nVaccines\n\nPrimer dose, 34,094,048\n\nBooster dose, 14,043,961\n\nTotal doses, 48,138,009\n\nIndia\n\nCases, + 379,257 \n\nTurkey\n\nUK variant in Turkey\n\nPopulation, 82 million\n\n22 million vaccinated\n\nSinovac vaccine and some Pfizer-BioNtech\n\nSputnik V soon\n\nMarch easing\n\nAK Party congresses in March, packed\n\nEarly April, some restriction\n\n19:00 today until 17 May\n\nRamadan and the Eid\n\nUS\n\nCases, + 50,061 = 31,976,888\n\nDeaths, + 556 = 570,421\n\nVaccination\n\nAt least 1 dose, 142,692,987 (43%)\n\nFully vaccinated, 98,044,421 (29.5%)\n\nUS, Guidance for Fully Vaccinated People\n\nhttps://www.cdc.gov/coronavirus/2019-ncov/vaccines/fully-vaccinated-guidance.html\n\nCan\n\nVisit with other fully vaccinated people indoors without wearing masks or physical distancing\n\nVisit with unvaccinated people (including children) from a single household who are at low risk for severe COVID-19 disease\n\nParticipate in outdoor activities and recreation without a mask\n\nResume domestic travel and refrain from testing before or after travel or self-quarantine after travel\n\nResume international travel, no self-quarantine after arriving back in the United States\n\nRefrain from testing following a known exposure, if asymptomatic, with some exceptions for specific settings\n\nRefrain from quarantine following a known exposure if asymptomatic\n\nContinue to wear a mask\n\nVisiting indoors with unvaccinated people who are at increased risk\n\nVisiting indoors with unvaccinated people from multiple households\n\nAvoid indoor large-sized in-person gatherings\n\nGet tested if symptomatic\n\nUS to EU travel\n\nhttps://www.dw.com/en/coronavirus-eu-set-to-allow-vaccinated-us-tourists-this-summer-report/a-57331605\n\nUrsula von der Leyen, vaccinated US tourists should be able to travel the EU summer\n\nThe Americans, as far as I see, use European Medicines Agency-approved vaccines\n\nThis will enable free movement and travel to the European Union\n\nRestrictions to be lifted depending on the epidemiological situation in the US\n\nEuropean Internal Market Commissioner Thierry Breto\n\nEU has procured enough doses of vaccine to achieve herd immunity by mid-July\n\nNew deal with Pfizer for 1.8 billion doses (now to 2023)\n\nhttps://www.dw.com/en/eu-puts-faith-in-pfizer-jab-with-plan-for-18-billion-doses/a-57201551\n\n50 million extra Pfizer doses for the second quarter of this year\n\nApril, May and June to 250 million Pfizer doses being delivered", "link": "https://www.youtube.com/watch?v=zd5i3768Jnc", "date_published": "2021-04-29 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]